LDL Cholesterol Modulates Human CD34+ HSPCs through Effects on Proliferation and the IL-17 G-CSF Axis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Cimato, Thomas R ^a   Palka, Beth A ^a   Lang, Jennifer K ^a   Young, Rebeccah F ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CD47 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 17; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN;

ADULT; ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CELL MIGRATION; CELL MOTILITY; CELL POPULATION; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERCHOLESTEROLEMIA; IMMUNOCOMPETENT CELL; LEUKOCYTE; MALE; NORMAL HUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADULT; ANTIGENS, CD34; CELL PROLIFERATION; CHOLESTEROL, LDL; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED;

EID: 84883065566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073861     Document Type: Article

References (22)

1. Swirski FK, Nahrendorf M, (2013) Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339: 161-166. doi:10.1126/science.1230719. PubMed: 23307733.
2. Minder CM, Blaha MJ, Horne A, Michos ED, Kaul S, et al. (2012) Evidence-based use of statins for primary prevention of cardiovascular disease. Am J Med 125: 440-446. doi:10.1016/j.amjmed.2011.11.013. PubMed: 22387091.
3. Soehnlein O, Swirski FK, (2013) Hypercholesterolemia links hematopoiesis with atherosclerosis. Trends Endocrinol Metab 24: 129-136. doi:10.1016/j.tem.2012.10.008. PubMed: 23228326.
4. Massberg S, Schaerli P, Knezevic-Maramica I, Köllnberger M, Tubo N, et al. (2007) Immunosurveilence by hematopoietic progenitor cells through blood, lymph and peripheral tissues. Cell 131: 994-1008. doi:10.1016/j.cell.2007.09.047. PubMed: 18045540.
5. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, et al. (2005) Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105: 199-206. doi:10.1182/blood-2004-05-1831. PubMed: 15345590.
6. Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, et al. (2013) Myocardial infarction accelerates atherosclerosis. Nature 487: 325-329. doi:10.1038/nature11260. PubMed: 22763456.
7. Coller BS, (2005) Leukocytosis and ischemic vascular disease morbidity and mortality: Is it time to intervene? Arterioscler Thromb Vasc Biol 25: 658-670. doi:10.1161/01.ATV.0000156877.94472.a5. PubMed: 1566202610.1161/01.ATV.0000156877.94472.a5.
8. Gomes AL, Carvalho T, Serpa J, Torre C, Dias S, (2010) Hypercholesterolemia promotes bone marrow mobilization by perturbing the SDF-1: CXCR-4 axis. Blood 115: 3886-3894. doi:10.1182/blood-2009-08-240580. PubMed: 20009035.
9. Feng Y, Schouteden S, Geenens R, Van Duppen V, Herijgers P, et al. (2012) Hematopoietic stem/progenitor cell proliferation and differentiation is differentially regulated by high-density and low-density lipoproteins in mice. PLOS ONE 7: e47286. doi:10.1371/journal.pone.0047286. PubMed: 23144813.
10. Westerterp M, Gourion-Arsiquaud S, Murphy AJ, Shih A, Cremers S, et al. (2012) Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell 11: 195-206. doi:10.1016/j.stem.2012.04.024. PubMed: 22862945.
11. Westerterp M, Murphy AJ, Wang M, Pagler TA, Vengrenyuk Y, et al. (2013) Deficiency of ABCA1 and ABCG1 in macrophages increases inflammation and accelerates atherosclerosis in mice. Circ Res 112: 1456-1465. doi:10.1161/CIRCRESAHA.113.301086. PubMed: 23572498.
12. The LIPID Study Group (1998); Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339(1349-57) doi:10.1056/NEJM199811053391902.
13. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation 97: 1837-1847. doi:10.1161/01.CIR.97.18.1837. PubMed: 960353910.1161/; 01.CIR. 97: 18 (1837).
14. Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, et al. (2010) Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329: 1345-1348. doi:10.1126/science.1191536. PubMed: 20688981.
15. Mayani H, Alvarado-Moreno JA, Flores-Guzmán P, (2003) Biology of human hematopoietic stem and progenitor cells present in circulation. Arch Med Res 34: 476-488. doi:10.1016/j.arcmed.2003.08.004. PubMed: 14734087.
16. Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, et al. (2009) CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138: 271-285. doi:10.1016/j.cell.2009.05.046. PubMed: 19632178.
17. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, et al. (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183: 2593-2603. doi:10.1084/jem.183.6.2593. PubMed: 8676080.
18. Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, et al. (2005) Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22: 285-294. doi:10.1016/j.immuni.2005.01.011. PubMed: 15780986.
19. Miossec P, Kolls JK, (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 11: 763-776. doi:10.1038/nrd3794. PubMed: 23023676.
20. Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, et al. (2008) IL-21 and TGFβ are required for differentiation of human TH17 cells. Nature 454: 350-352. doi:10.1038/nature07021. PubMed: 18469800.
21. Manel N, Unutmaz D, Littman DR, (2008) The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat Immunol 9: 641-649. doi:10.1038/ni.1610. PubMed: 18454151.
22. Jin L, Martynowski D, Zheng S, Wada T, Xie W, et al. (2010) Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORγ. Mol Endocrinol 24: 923-929. doi:10.1210/me.2009-0507. PubMed: 20203100.